US Patent

US8207197 — Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy] propyl] -piperidine

Composition of Matter · Assigned to Bioprojet SC · Expires 2030-03-07 · 4y remaining

Vulnerability score 10/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects the new crystalline form of the monohydrochloride salt of 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine.

USPTO Abstract

The invention relates to new crystalline 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine monohydrochloride, the respective manufacture and methods of use, and compositions containing such a compound.

Drugs covered by this patent

pitolisant-hydrochloride (PITOLISANT HYDROCHLORIDE)

Patent Metadata

Patent number: US8207197
Jurisdiction: US
Classification: Composition of Matter
Expires: 2030-03-07
Drug substance claim: Yes
Drug product claim: Yes
Assignee: Bioprojet SC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.